Kidney care startup VitusCare raises $2.7 million from Tomorrow Capital, others

Gurugram-based kidney care startup VitusCare has raised $2.7 million led by venture capital fund Tomorrow Capital, according to a company's statement.

In the fresh round of Series A, existing investor 1Crowd, alongwith 3i Partners and a consortium of angel investors, also participated. With this, the company's total external funding is now around $5 million.

In the health-tech startup space, emergency healthcare services provider Medulance has also raised $3 million in a Series A round of funding today. The round was led by Alkemi Growth Capital. 

The funding will empower VitusCare to aggressively expand its operations, with a targeted focus on deeper penetration into 'Bharat'.

"As the prevalence of lifestyle-related disorders such as diabetes and hypertension continue to rise, the demand for kidney-related services is poised to increase exponentially. VitusCare's innovative approach and impressive growth trajectory align perfectly with our mission to invest in solutions that make a meaningful impact on public health," Tomorrow Capital CEO Rohini Prakash said.

VitusCare has around 30 centres currently operational across North India. It collaborates with existing hospitals to ensure seamless delivery of end-to-end dialysis services, including equipment provision, skilled technicians, and patient care.

"Tomorrow Capital's investment marks a significant milestone for VitusCare as we embark on our mission to deliver high-quality, patient-centric care to underserved regions of India. This fundraising will be pivotal in accelerating our expansion efforts and scaling our operations to meet the growing demand for quality dialysis care," VitusCare Co-Founder & CEO Prabhat Shrivastava said.

In the startup space, AI startup Upstage has also secured over $71 million to expand globally.